PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: hkitaga@hiroshima-u.ac.jp.\', \'Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.\', \'Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: aya-sugiyama@hiroshima-u.ac.jp.\', \'Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.\', \'Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.\', \'Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Translational Research Center, Hiroshima University, Hiroshima, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1341-321X(22)00002-210.1016/j.jiac.2021.12.034
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 35058126
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all